Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin

Carbohydrate Polymers

Volumn 123, Issue , 2015, Pages 313-323

  Pradhan, Roshan ^a   Ramasamy, Thiruganesh ^a   Choi, Ju Yeon ^a   Kim, Jeong Hwan ^a   Poudel, Bijay Kumar ^a   Tak, Jin Wook ^a   Nukolova, Natalia ^b   Choi, Han Gon ^c   Yong, Chul Soon ^a   Kim, Jong Oh ^a  

^a Yeungnam University   (South Korea)

^b Serbsky National Research Center for Social and Forensic Psychiatry   (Russian Federation)

^c Hanyang University   (South Korea)

Author keywords

Combined therapy; Docetaxel; Poly(lactic co glycolic acid); Synergic effect; Tanespimycin

Indexed keywords

COPOLYMERS; DRUG DOSAGE; DRUG PRODUCTS; DRUG THERAPY; EMULSIFICATION; NANOPARTICLES; ORGANIC ACIDS; PARTICLE SIZE;

COMBINED THERAPY; DOCETAXEL; POLY LACTIC-CO-GLYCOLIC ACID; SYNERGIC EFFECTS; TANESPIMYCIN;

HYALURONIC ACID;

MUS MUSCULUS;

ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; DOCETAXEL; DRUG CARRIER; EMULSION; HYALURONIC ACID; LACTIC ACID; MACROCYCLIC LACTAM; NANOPARTICLE; OIL; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TANESPIMYCIN; TAXOID; WATER;

ANIMAL; BODY WEIGHT; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; EMULSION; HUMAN; MOUSE; NUDE MOUSE; PARTICLE SIZE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOQUINONES; BODY WEIGHT; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; EMULSIONS; HUMANS; HYALURONIC ACID; LACTAMS, MACROCYCLIC; LACTIC ACID; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; NANOPARTICLES; OILS; PARTICLE SIZE; POLYGLYCOLIC ACID; TAXOIDS; TRANSPLANTATION, HETEROLOGOUS; WATER;

EID: 84922792533     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2015.01.064     Document Type: Article

References (44)

1. S. Amatya, E.J. Park, J.H. Park, J.S. Kim, E.Y. Seol, and H.Y. Lee Drug release testing methods of polymeric particulate drug formulations Journal of Pharmaceutical Investigation 43 4 2013 259 266
2. H. Cho, T.C. Lai, and G.S. Kwon Poly(ethylene glycol)-block-poly((-caprolactone) micelles for combination drug delivery: Evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer Journal of Controlled Release 166 1 2013 1 9
3. T.C. Chou, and P. Talaly A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems The Journal of Biological Chemistry 252 18 1977 6438 6442
4. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A.L. Breton, and V. Preat PLGA-based nanoparticles: An overview of biomedical applications Journal of Controlled Release 161 2 2012 505 522
5. M.E. Davis, Z. Chen, and D.M. Shin Nanoparticle therapeutics: An emerging treatment modality for cancer Nature Reviews Drug Discovery 7 9 2008 771 782
6. S. Guo, C.M. Lin, Z. Xu, L. Miao, Y. Wang, and L. Huang Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation ACS Nano 27 5 2014 4996 5009
7. C.M. Hu, S. Aryal, and L. Zhang Nanoparticle-assisted combination therapies for effective cancer treatment Therapeutic Delivery 1 2 2010 323 334
8. J. Huang, H. Zhang, Y. Yu, Y. Chen, D. Wang, and G. Zhang Biodegradable self-coated nanoparticles of poly(d,l-lactide-co-glycolide)/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer Biomaterials 35 1 2014 550 566
9. Y.I. Jeong, D.H. Kim, C.W. Chung, J.J. Yoo, K.H. Choi, and C.H. Kim Self-assembled nanoparticles of hyaluronic acid/poly(dl-lactide-co-glycolide) block copolymer Colloids and Surfaces B: Biointerfaces 90 1 2012 28 35
10. J. Jia, F. Zhu, X. Ma, Z. Cao, Y. Li, and Y.Z. Chen Mechanisms of drug combinations: Interaction and network perspectives Nature Reviews Drug Discovery 8 2 2009 111 128
11. K.W. Kang, M.K. Chun, O. Kim, R.K. Subedi, S.G. Ahn, and J.H. Yoon Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy Nanomedicine: Nanotechnology, Biology and Medicine 6 2 2010 210 213
12. S. Karl, Y. Pritschow, M. Volcic, S. Hacker, B. Baumann, and L. Wiesmuller Identification of a novel pro-apopotic function of NF-kappaB in the DNA damage response Journal of Cellular and Molecular Medicine 13 10 2009 4239 4256
13. U. Katragadda, W. Fan, Y. Wang, Q. Teng, and C. Tan Combined delivery pf paclitaxel and tanespimycin via mecellar nanocarriers: Pharmacokinetics, efficacy and metabolomics analysis PLOS ONE 8 3 2013 e58619
14. C.G. Keum, Y.W. Noh, J.S. Baek, J.H. Lim, C.J. Hwang, and Y.G. Na Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid International Journal of Nanomedicine 6 2011 2225 2234
15. A. Kumari, S.K. Yadav, and S.C. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids and Surfaces B: Biointerfaces 75 1 2010 1 18
16. H.Y. Kwon, J.Y. Lee, S.W. Choi, Y. Jang, and J.H. Kim Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method Colloids and Surfaces A: Physicochemical and Engineering Aspects 182 1-3 2001 123 130
17. D. Lane Designer combination therapy for cancer Nature Biotechnology 24 2 2006 163 164
18. J.H. Lee, and A. Nan Combination drug delivery approaches in metastatic breast cancer Journal of Drug Delivery 2012 17 10.1155/2012/915375 (Article ID 915375)
19. J. Lehar, A.S. Krueger, W. Avery, A.M. Heilbut, L.M. Johansen, and E.R. Price Synergistic drug combinations tend to improve therapeutically relevant selectivity Nature Biotechnology 27 7 2009 659 666
20. Y. Luo, M.R. Ziebell, and G.D. Prestwich A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells Biomacromolecules 1 2 2000 208 218
21. G. Mittal, D.K. Sahana, V. Bhardwaj, and M.N.V.R. Kumar Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo Journal of Controlled Release 119 1 2007 77 85
22. S. Modi, A. Stopeck, H. Linden, D. Solit, S. Chandarlapaty, and N. Rosen HSP90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab Clinical Cancer Research 17 15 2011 5132 5139
23. S. Pacey, M. Gore, D. Chao, U. Banerji, J. Larkin, and S. Sarker A phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma Investigational New Drugs 30 1 2012 149 341
24. M.H. Park, J.S. Baek, C.A. Lee, and C.W. Cho Effect of chitosan on physicochemical properties of exenatide-loaded PLGA nanoparticles Journal of Pharmaceutical Investigation 43 6 2013 489 497
25. R. Pradhan, B.K. Poudel, J.Y. Choi, I.S. Choi, B.S. Sin, and H.G. Choi Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticles Archives of Pharmacal Research 2014 (in press)
26. R. Pradhan, B.K. Poudel, T. Ramasamy, H.G. Choi, C.S. Yong, and J.O. Kim Docetaxel-loaded PLGA nanoparticles: Formulation, physicochemical characterization and cytotoxicity studies Journal of Nanoscience and Nanotechnology 13 8 2013 5948 5956
27. H.S.S. Qhattal, and X. Liu Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes Molecular Pharmaceutics 8 4 2011 1233 1246
28. S.S. Ramalingan, M.J. Egorin, R.K. Ramanathan, S.C. Remick, R.P. Sikorski, and T.F. Lagattuta A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies Clinical Cancer Research 14 11 2008 3456 3461
29. T. Ramasamy, J. Kim, H.G. Choi, C.S. Yong, and J.O. Kim Novel dual drug-loaded block ionomer complex micelles for enhancing the efficacy of chemotherapy treatments Journal of Biomedical Nanotechnology 10 7 2014 1304 1312
30. T. Ramasamy, T.H. Tran, J.Y. Choi, H.J. Cho, J.H. Kim, and C.S. Yong Layer-by-layer coated lipid-polymer hybrid nanoparticles designed for use in anticancer drug delivery Carbohydrate Polymers 102 15 2014 653 661
31. P.G. Richardson, A.A. Chanan-Khan, M. Alsina, M. Albitar, D. Berman, and M. Messina Tanespimycin monotherapy in relapsed multiple myeloma: Results of a phase 1 dose-escalation study British Journal of Haematology 150 4 2010 438 445
32. I. Rivkin, K. Cohen, J. Koffler, D. Melikhov, D. Peer, and R. Margalit Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors Biomaterials 31 27 2010 7106 7114
33. M. Saad, O.B. Garbuzenko, and T. Minko Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer Nanomedicine 3 6 2008 761 776
34. N. Sain, B. Krishnan, M.G. Ormerod, A. De Rienzo, W.M. Liu, and S.B. Kaye Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT Molecular Cancer Therapeutics 5 5 2006 1197 1208
35. A. Sawai, S. Chandarlapaty, H. Greulich, M. Gonen, Q. Ye, and C.L. Arteaga Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel Cancer Research 68 2 2008 589 596
36. H.C. Shin, A.W.G. Alani, D.A. Rao, N.C. Rockich, and G.S. Kwon Multi-drug polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs Journal of Controlled Release 140 3 2009 294 300
37. D.B. Solit, I. Osman, D. Polsky, K.S. Panageas, A. Daud, and J.S. Goydos Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma Clinical Cancer Research 14 24 2008 8302 8307
38. R.D. Toro, V. Betti, and S. Spampinato Biocompatibility and integrin-mediated adhesion of human osteoblasts to poly(dl-lactide-co-glycolide) copolymers European Journal of Pharmaceutical Sciences 21 2-3 2004 161 169
39. H. Wang, P. Zhao, W. Su, S. Wang, Z. Liao, and R. Niu PLGA/polymeric liposome for targeted drug and gene co-delivery Biomaterials 31 33 2010 8741 8748
40. H. Wang, Y. Zhao, Y. Wu, Y.L. Hu, K. Nan, and G. Nie Enhanched anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with Amphiphilic methoxy PEG-PLGA copolymer nanoparticles Biomaterials 32 32 2011 8281 8290
41. M.Y. Wong, and G.N.C. Chiu Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model Nanomedicine: Nanotechnology, Biology and Medicine 7 6 2011 834 840
42. M.P. Xiong, J.A. Yanez, G.S. Kwon, N.M. Davies, and M. Laird Forrest A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles:characterization and pharmacokinetics in rats Journal of Pharmaceutical Sciences 98 4 2009 1577 1586
43. M. Zheng, C. Yue, Y. Ma, P. Gong, P. Zhao, and C. Zheng Single-step assembly of DOX/ICG loaded lipid polymer nanoparticles for highly effective chemo-photo thermal combination therapy ACS Nano 7 3 2013 2056 2067
44. Y. Zhou, L. Feng, T. Mueller, F. Liu, and R.G. Johnson Jr. 17-AAG (KOS-953), an inhibitor of Hsp90 function, significantly enhances the cytotoxicity of anticancer drugs: An effective approach for combination therapy AACR Meeting Abstracts 2004 2004 458-b